Experimental stages—effect on MDSC, in the context of TB, yet to be evaluated. In a TB model, anti-VEGF treatment promotes vascular normalization, reduces hypoxic areas within the TB granuloma and thereby provide improved delivery mechanisms for current anti-Tuberculosis therapies. Murine and human infection model. The gene discussed is VEGFA; the disease is infection.